Incidence of nonmelanoma skin cancer after human organ transplantation: Single-center experience in Hungary

T. Fekecs, Z. Kádár, Z. Battyáni, K. Kalmár-Nagy, P. Szakály, Ó P. Horváth, G. Wéber, A. Ferencz

Research output: Contribution to journalArticle

11 Citations (Scopus)


There is increasing evidence that nonmelanoma skin cancers (NMSCs) are the most frequently observed tumors in transplant recipients. The incidence of posttransplantation NMSC was determined using our dermatologic screening program. Included in the study were 116 white adults (70 men and 46 women; median age, 49.3 years) who had undergone kidney or combined kidney-pancreas transplantation, with follow-up from September 2008 to December 2009. All patients underwent a full skin examination for NMSC, and completed a standardized questionnaire. Screening resulted in detection of 16 NMSCs in 11 patients out of 116 (9.5%). Lesions were equally distributed by sex, and were detected at a median of 4.1 years posttransplantation. Histologic analysis verified 13 basal cell carcinomas and 3 squamous cell carcinomas (ratio, 4:1). The incidence of NMSC was significantly greater in patients who received cyclosporine immunosuppression therapy (16 vs 1; P < .05), had experienced 2 or more painful sunburns before transplantation (10 vs 11), or worked outdoors (10 vs 11). These data indicate the relevance of skin cancer surveillance in transplant recipients. Our results correspond to international statistics except for the ratio of basal cell carcinoma to squamous cell carcinoma. Further studies are needed to elucidate the reasons for this difference.

Original languageEnglish
Pages (from-to)2333-2335
Number of pages3
JournalTransplantation proceedings
Issue number6
Publication statusPublished - Jul 1 2010

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Fingerprint Dive into the research topics of 'Incidence of nonmelanoma skin cancer after human organ transplantation: Single-center experience in Hungary'. Together they form a unique fingerprint.

  • Cite this